Brief: Avalo Therapeutics Announces Active IND for AVTX-009 To Treat Hidradenitis Suppurativa

Avalo Therapeutics

09/07/2024 12:23

July 9 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO THERAPEUTICS ANNOUNCES ACTIVE IND FOR AVTX-009, AN
ANTI-IL-1Β MAB, TO TREAT HIDRADENITIS SUPPURATIVA
    * AVALO THERAPEUTICS INC - AVALO EXPECTS TO ENROLL FIRST
PATIENT
IN ITS PHASE 2 LOTUS TRIAL THIS YEAR

Source text for Eikon:  ID:nGNX90zxDw 
Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))